Projects per year
Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 8 Similar Profiles
Introns
Medicine & Life Sciences
Catalysis
Medicine & Life Sciences
Metals
Medicine & Life Sciences
Ions
Medicine & Life Sciences
Metal ions
Chemical Compounds
Spliceosomes
Medicine & Life Sciences
irinotecan
Medicine & Life Sciences
Nanoparticles
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2014 2020
A Phase 2 Study of Inotuzumab Ozogamicin in Children and Young Adults with Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)
Children's Hospital of Philadelphia
2/27/19 → 2/28/20
Project: Research project
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Young Adult
Inotuzumab Ozogamicin
Targeted Therapy of the Rare, Chemo-resistant Leukemia Cells that Contribute to Relapse
Hope on Wheels Hyundai Dealers
10/22/18 → 12/30/20
Project: Research project
Leukemia
Recurrence
Therapeutics
AALL0434 - Novartis Pharmaceuticals Corporation
Children's Hospital of Philadelphia
7/1/18 → 6/30/20
Project: Research project
Pharmaceutical Preparations
Industry
A Phase 2 Study of the JAK1/JA2 Inhibitor Ruxolitinib
Children's Hospital of Philadelphia
7/1/16 → 1/31/20
Project: Research project
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Drug Therapy
N-carboxy-3-phenylpropyl-alanyl-aminoisobutyric acid-tyrosyl-aminobenzoate
INCB018424
Research Output 1999 2019
Ruxolitinib combined with chemotherapy can eradicate chemorefractory central nervous system acute lymphoblastic leukaemia
Ebadi, M., Wasko, J., Weisdorf, D. J., Gordon, P. M. & Rashidi, A., Jan 1 2019, In : British Journal of Haematology.Research output: Contribution to journal › Letter
Open Access
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Central Nervous System
Drug Therapy
INCB018424
4
Citations
(Scopus)
SN-38 Conjugated Gold Nanoparticles Activated by Ewing Sarcoma Specific mRNAs Exhibit in Vitro and in Vivo Efficacy
Naumann, J. A., Widen, J. C., Jonart, L. A., Ebadi, M., Tang, J., Gordon, D. J., Harki, D. A. & Gordon, P. M., Apr 18 2018, In : Bioconjugate Chemistry. 29, 4, p. 1111-1118 8 p.Research output: Contribution to journal › Article
irinotecan
Ewing's Sarcoma
Gold
Nanoparticles
Cells
2
Citations
(Scopus)
In vitro model of leukemia cell migration across the blood–cerebrospinal fluid barrier
Naumann, J. A. & Gordon, P. M., Jul 3 2017, In : Leukemia and Lymphoma. 58, 7, p. 1747-1749 3 p.Research output: Contribution to journal › Letter
Cell Movement
Cerebrospinal Fluid
Leukemia
In Vitro Techniques
4
Citations
(Scopus)
Open Access
4
Citations
(Scopus)
The central nervous system microenvironment influences the leukemia transcriptome and enhances leukemia chemo-resistance
Gaynes, J. S., Jonart, L. M., Zamora, E. A., Naumann, J. A., Gossai, N. P. & Gordon, P. M., Mar 31 2017, In : Haematologica. 102, 4, p. e136-e139Research output: Contribution to journal › Letter
Open Access